Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34


Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

Makarenko I, Mazhnaya A, Marcus R, Bojko MJ, Madden L, Filippovich S, Dvoriak S, Altice FL.

Int J Drug Policy. 2017 Jul;45:56-63. doi: 10.1016/j.drugpo.2017.05.037. Epub 2017 Jun 16.


Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.

Bazazi AR, Wickersham JA, Wegman MP, Culbert GJ, Pillai V, Shrestha R, Al-Darraji H, Copenhaver MM, Kamarulzaman A, Altice FL.

Contemp Clin Trials. 2017 Aug;59:1-12. doi: 10.1016/j.cct.2017.05.006. Epub 2017 May 4.


A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs.

Gilchrist G, Swan D, Widyaratna K, Marquez-Arrico JE, Hughes E, Mdege ND, Martyn-St James M, Tirado-Munoz J.

AIDS Behav. 2017 Jul;21(7):1791-1811. doi: 10.1007/s10461-017-1755-0. Review.


The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual.

Gilchrist G, Swan D, Shaw A, Keding A, Towers S, Craine N, Munro A, Hughes E, Parrott S, Strang J, Taylor A, Watson J.

Harm Reduct J. 2017 Mar 21;14(1):14. doi: 10.1186/s12954-017-0142-5.


Adapting an Evidence-Based HIV Prevention Intervention Targeting High-Risk Migrant Workers: The Process and Outcome of Formative Research.

Shrestha R, Karki P, Pandey S, Copenhaver M.

Front Public Health. 2016 Mar 31;4:61. doi: 10.3389/fpubh.2016.00061. eCollection 2016.


Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Huedo-Medina TB, Shrestha R, Copenhaver M.

AIDS Behav. 2016 Aug;20(8):1646-57. doi: 10.1007/s10461-016-1394-x.


Advancing Behavioral HIV Prevention: Adapting an Evidence-Based Intervention for People Living with HIV and Alcohol Use Disorders.

Armstrong ML, LaPlante AM, Altice FL, Copenhaver M, Molina PE.

AIDS Res Treat. 2015;2015:879052. doi: 10.1155/2015/879052. Epub 2015 Dec 1.


A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Shrestha R, Krishnan A, Altice FL, Copenhaver M.

Contemp Clin Trials. 2015 Sep;44:95-102. doi: 10.1016/j.cct.2015.08.002. Epub 2015 Aug 5.


Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention.

Syvertsen JL, Agot K, Ohaga S, Strathdee SA, Camlin CS, Omanga E, Odonde P, Rota G, Akoth K, Peng J, Wagner KD.

Drug Alcohol Depend. 2015 Jun 1;151:262-6. doi: 10.1016/j.drugalcdep.2015.02.037. Epub 2015 Mar 14.


Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States.

Song DL, Altice FL, Copenhaver MM, Long EF.

PLoS One. 2015 Feb 6;10(2):e0116694. doi: 10.1371/journal.pone.0116694. eCollection 2015.


Methadone treatment in Iranian opiate addicts: a preliminary report.

Eslami Shahrbabaki M, Ziaaddini H, Hagh Doost AA, Ghasemi M, Eslami Shahrbabaki P, Alizadeh Nouri R, Eslami Shahrbabaki N.

Addict Health. 2011 Winter-Spring;3(1-2):53-60.


Impact of one-year methadone maintenance treatment in heroin users in jiangsu province, china.

Chen G, Fujiwara T.

Subst Abuse. 2009 Sep 23;3:61-70. eCollection 2009.


Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine.

Bachireddy C, Soule MC, Izenberg JM, Dvoryak S, Dumchev K, Altice FL.

Drug Alcohol Depend. 2014 Jan 1;134:106-114. doi: 10.1016/j.drugalcdep.2013.09.020. Epub 2013 Sep 27.


A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment.

Copenhaver MM, Lee IC, Baldwin P.

AIDS Behav. 2013 Nov;17(9):2902-13. doi: 10.1007/s10461-013-0539-4.


Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.

Phillips KT, Altman JK, Corsi KF, Stein MD.

Subst Use Misuse. 2013 Jan;48(1-2):54-64. doi: 10.3109/10826084.2012.722159. Epub 2012 Sep 27.


Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment.

Marsch LA, Dallery J.

Psychiatr Clin North Am. 2012 Jun;35(2):481-93. doi: 10.1016/j.psc.2012.03.009. Epub 2012 Apr 11. Review.


Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.

Phillips KT, Stein MD, Anderson BJ, Corsi KF.

J Subst Abuse Treat. 2012 Oct;43(3):313-21. doi: 10.1016/j.jsat.2012.01.003. Epub 2012 Feb 14.


Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.

Springer SA, Spaulding AC, Meyer JP, Altice FL.

Clin Infect Dis. 2011 Sep;53(5):469-79. doi: 10.1093/cid/cir446. Erratum in: Clin Infect Dis. 2011 Oct;53(8):851.

Supplemental Content

Support Center